While the physiological vasculogenesis and angiogenesis are intact in VAP-1 knockout mice (126), SSAO inhibitors reduce aberrant angiogenesis in several eye disease models, including a laser-induced choroidal damage and a cytokine-induced corneal micropocket assay (97, 100). Here, AOC3 is linked to eye disorder.